Andrew Dudum
Founder and CEO @ Hims
San Francisco, United States
Andrew Dudum is a seed investor at Hims in San Francisco focused on Health Care and Pet. Andrew is a Cofounder and General Partner at Atomic, a venture-builder in San Francisco backed by Peter Thiel, Marc Andreessen and many of the leading venture funds in the world. He is serial founder, active angel investor and advisor to over two dozen startups. Andrew graduated from the Wharton School of the University of Pennsylvania withconcentrations in Entrepreneurial Management and Venture Capital.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Andrew Dudum invests in
Stages Andrew Dudum invests in
Countries Andrew Dudum invests in
Investment Focus
Industry
- Health Care 2 (40%)
- Pet 1 (20%)
- FinTech 1 (20%)
- Finance 1 (20%)
- Wellness 1 (20%)
Stage
- Seed 2 (40%)
- Series A 2 (40%)
Country
- United States 3 (60%)
- United Kingdom 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Summer Health
|
Summer Health is the first step and ongoing tool for anyone navigating health concerns, offering timely text access to high-quality healthcare professionals who provide expert answers and reliable advice over text. | $7.5M / Seed / Jul 25, 2022 | |
Front of the Pack
|
Pet wellness, reimagined. | $10M / Series A / Jul 14, 2021 | |
Dutch
|
At Dutch, we’re on a mission to treat the curable ailments that keep our pets from living their best lives. Many of our pets suffer from chronic conditions such as allergies and anxiety. Sadly, many also go untreated. Traditional vet appointments are inconvenient, expensive and often stressful for our best friends. This leads to putting offwellness visits until a pain point is unignorable and frequently pushing quality-of-life issues under the rug. This is the reality of pet healthcare in the U.S. — but we know we can do better. By using telehealth solutions to connect pet parents with licensed veterinarians, Dutch makes veterinary visits convenient and practical. Dutch-affiliated vets work with your pet over time, whenever they need it, allowing our veterinarians to go beyond the symptoms and identify the root cause of your pet’s chronic suffering. We prescribe treatments and prescriptions that are medically-backed, specialized to individual cases and delivered directly to your door. Dutch currently operates in the following eight states: New York, Pennsylvania, New Jersey, Michigan, South Dakota, Virginia, Idaho and Indiana. We're continuing to add more states rapidly, so stay tuned!Pet parents can visit dutch.com to begin a virtual consultation. | $5M / Seed / Jul 02, 2021 | |
Collective
|
Collective operates as an online back-office platform designed for self-employed people. Its technology and a team of trusted advisors give its members the freedom to focus on what matters by taking care of everything from business incorporation to accounting, bookkeeping, tax services, and access to a community all in one platform. | $20M / Series A / May 12, 2021 | |
|
Collective
|
Collective operates as an online back-office platform designed for self-employed people. Its technology and a team of trusted advisors give its members the freedom to focus on what matters by taking care of everything from business incorporation to accounting, bookkeeping, tax services, and access to a community all in one platform. | $20M / Series A / May 12, 2021 |
Co-Investors
About Hims
Hims & Hers connects consumers with licensed medical professionals and enables everyone to seek health and wellness care. Its mission is to eliminate stigmas and make it easier for people to access care and treatment for the conditions that impact their daily lives. With a telemedicine approach, customers can get diagnosed and treated at alower cost and with greater convenience. Hims was incubated at San Francisco-based venture-builder, Atomic by Andrew Dudum and Jack Abraham in 2017. At first, the focus was on providing telehealth services, such as for erectile dysfunction and hair loss. But HIMS would quickly expand its platform. And in 2018, there was the launch of Hers. It also moved into categories like mental health, dermatology, and primary care. To help with the management of the growing organization, HIMS created its own EHR (Electronic Health Record) system. The company also has partnered with a variety of health care operators — such as Ochsner Health, Mount Sinai Health System, and Privia Health — to provide access to in-person visits with doctors.
Hims Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andrew Dudum
Founder and CEO
|
|||
Don Holly
Engineer
|
|||
Tim Doyle
SVP of International
|
|||
Alexander Lim
Investor
|
|||
Alexander Lim
Investor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Andrew Dudum invest in?
Andrew Dudum invests primarily in Health Care, Pet and FinTech startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andrew Dudum last invest?
The most recent investment recorded for Andrew Dudum closed in Jul 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
